Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
7.78
-0.10 (-1.27%)
Dec 2, 2025, 9:54 AM EST - Market open
Nuvation Bio Market Cap
Nuvation Bio has a market cap or net worth of $2.67 billion as of December 2, 2025. Its market cap has increased by 168.64% in one year.
Market Cap
2.67B
Enterprise Value
2.21B
1-Year Change
168.64%
Ranking
Category
Stock Price
$7.78
Market Cap Chart
Since August 26, 2020, Nuvation Bio's market cap has increased from $174.48M to $2.67B, an increase of 1,428.69%. That is a compound annual growth rate of 67.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 1, 2025 | 2.70B | 201.76% |
| Dec 31, 2024 | 895.27M | 170.80% |
| Dec 29, 2023 | 330.61M | -21.16% |
| Dec 30, 2022 | 419.31M | -77.35% |
| Dec 31, 2021 | 1.85B | 779.62% |
| Dec 31, 2020 | 210.45M | 20.62% |
| Aug 26, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.96B |
| Johnson & Johnson | 498.53B |
| AbbVie | 402.43B |
| UnitedHealth Group | 298.72B |
| AstraZeneca | 286.85B |
| Merck & Co. | 260.19B |
| Novartis AG | 249.40B |
| Abbott Laboratories | 224.14B |